Antimicrobial susceptibility testing ofArcobacter butzleriandArcobacter cryaerophilusstrains isolated from Belgian patients
Open Access
- 6 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 71 (5) , 1241-1244
Abstract
To evaluate the feasibility of different methods for susceptibility testing of human Arcobacter isolates, to assess susceptibility to antibiotics commonly used to treat diarrhoeal illness and to obtain MIC distribution data. One-hundred-and-six unique Arcobacter strains were collected during an epidemiological study on pathogens in gastroenteritis. Strains were identified by multiplex PCR and PCR–RFLP, and characterized by PFGE. Susceptibility to ampicillin, erythromycin, tetracycline, doxycycline, gentamicin and ciprofloxacin was determined using gradient strip and disc diffusion methodology. Optimal conditions for growth and incubation were tested. Azithromycin was tested with gradient strip diffusion on a subset of 40 strains. Sequence analysis of the quinolone resistance-determining region of gyrA was performed for a subset of 18 strains. Based on gradient diffusion results, most Arcobacter strains were susceptible to gentamicin (99%) and tetracycline (89%). Erythromycin (78%), ciprofloxacin (72%) and doxycycline (76%) retained moderate activity against Arcobacter spp. Only 9% of the strains were susceptible to ampicillin. Most Arcobacter butzleri strains were susceptible to ciprofloxacin (87%), whereas half of the Arcobacter cryaerophilus isolates (51%) showed high-level resistance (MIC >32 mg/L). MIC50 values were comparable for both macrolide antibiotics. Ciprofloxacin-resistant strains possessed an identical mutation in gyrA. Overall, categorical agreement between gradient and disc diffusion results was 60%. Gradient diffusion showed superior readability. Gradient diffusion methodology is preferred for routine susceptibility testing. Acquired resistance to fluoroquinolones was observed in A. cryaerophilus. Macrolides are not first-choice empirical antibiotics for Arcobacter infections. Tetracyclines can be suggested for treatment of documented Arcobacter-related gastrointestinal infections.Keywords
This publication has 14 references indexed in Scilit:
- Evidence of Recombinant Strains of Porcine Epidemic Diarrhea Virus, United States, 2013Emerging Infectious Diseases, 2014
- Towards a Typing Strategy for Arcobacter Species Isolated from Humans and Animals and Assessment of the In Vitro Genomic StabilityFoodborne Pathogens and Disease, 2014
- The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food‐borne Outbreaks in 2011EFSA Journal, 2013
- Emerging pathogen Arcobacter spp. in acute gastroenteritis: molecular identification, antibiotic susceptibilities and genotyping of the isolated arcobactersJournal of Medical Microbiology, 2012
- In vitro Antibacterial Susceptibility of Arcobacter butzleri Isolated from Different SourcesJournal of Veterinary Medical Science, 2012
- Revisiting Bacterial Gastroenteritis, Part I: Issues, Possible Approaches, and an Ever-Expanding List of Etiologic AgentsClinical Microbiology Newsletter, 2011
- Taxonomy, Epidemiology, and Clinical Relevance of the Genus ArcobacterClinical Microbiology Reviews, 2011
- Nucleotide sequence of thegyrAgene ofArcobacterspecies and characterization of human ciprofloxacin-resistant clinical isolatesFEMS Immunology & Medical Microbiology, 2007
- Campylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, FranceEmerging Infectious Diseases, 2007
- Arcobacter butzleri: Underestimated EnteropathogenEmerging Infectious Diseases, 2006